News archive

Welcome to the Biognosys News archive

News archive

9/17/2019 PRESS RELEASE: Biognosys and Bruker Collaborate to Support Ion Mobility on timsTOF Pro with Spectronaut

Biognosys adds beta support for diaPASEF within Spectronaut, the industry leading data-independent acquisition (DIA) proteomics software.

8/16/2019 NEWSLETTER: Using DIA and Spectronaut for the Identification and Quantification of Host Cell Proteins (HCP)

Webinar with Dr. Christine Carapito on September 24th, 2019 – 4.00 PM (CEST).

8/16/2019 Biognosys Announces Presentation of Novel Proteomics Workflows at the Society for Neuroscience Annual Meeting

Two abstracts on Biognosys’ new workflows will be presented at the Society for Neuroscience (SfN) Annual Meeting in Chicago, Illinois from October 19-23, 2019.

8/8/2019 PRESS RELEASE: Biognosys Completes Series G Financing Round to Accelerate its Expansion into Clinical Trials Market

Biognosys closes Series G round with new and existing investors to accelerate implementation of discovery proteomics in clinical trials.

5/21/2019 NEWSLETTER: Biognosys to Present Latest Feature Updates of Spectronaut 13.0 at ASMS 2019

Biognosys attends ASMS 2019 with an array of posters, orals and exhibition booth (#517)

4/15/2019 NEWSLETTER: Biognosys to present new proteomic data at AACR and MSACL

Biognosys to present new data on applications of HRMTM mass spectrometry to support research for therapeutic development and clinical investigations

4/15/2019 NEWSLETTER: Big Launch Weekend: Biognosys reveals SpectroDive 9.0 and QuiC 3.0

Biognosys Introduces Two Major Software Updates and Pushes the Standards of Next Generation Proteomics

4/15/2019 NEWSLETTER: Biognosys publishes with SCIEX on digitizing proteomes from big tissue biobanks

Unlocking Big Tissue Biobanks: Analyzing the Proteome Using SWATH® Acquisition and Spectronaut Analysis

4/4/2019 PRESS RELEASE: Roche Presents Data from Biognosys for Use of Discovery Proteomics in Clinical Trials

Roche presents data from a mock clinical trial study suggesting that next generation discovery proteomics is ready for use in clinical trials.

2/27/2019 PUBLICATION: Comparison of protein quantification in a complex background by DIA and TMT workflows with fixed instrument time.

We proudly present our most recent publication on the “Comparison of protein quantification in a complex background by DIA and TMT workflows with fixed instrument time.”; the result...

2/22/2019 NEWSLETTER: Biognosys is expanding the scope and applications of protein-based biomarker discovery 

Mass-Spectrometry as an Unbiased Tool to Discover, Identify and Quantify Protein Biomarkers

2/1/2018 Webinar Reminder

6/2/2017 New Spectronaut™ Pulsar from Biognosys enables spectral library free DIA

It begins now. The new era in proteomics.

5/19/2017 It begins now.

The new era in discovery proteomics.

2/27/2017 Biognosys in-licenses a new technology published in Science

Unbiased and proteome-wide profiling of protein conformational changes

12/23/2016 End of Year

12/9/2016 Proteome profiling of aqueous humor in patients with glaucoma

Biognosys’ Discovery Proteomics Service was used to quantify hundreds of proteins in patients with glaucoma

11/11/2016 Biognosys and Moderna present a joint poster at the mRNA Health Conference Boston

Exploring the potential of using targeted proteomics for the high throughput quantification of protein expression after mRNA administration

8/24/2016 Don’t miss the webinars on DIA method development and the simplest targeted proteomics platform

If you haven’t yet registered we still have a couple of places left. We will send the recording of the webinar afterwards to all registrants.

8/19/2016 Biognosys will attend the IMSC 2016

We look forward to meeting you at the 21st International Mass Spectrometry Conference in Toronto

8/18/2016 Robert Moritz, Ruedi Aebersold, Leroy Hood and Biognosys publish work on SRMAtlas in Cell

We are happy to announce that Biognosys was involved in the development of the human SRMAtlas, a collection of proteomic assays for any human protein.

1/7/2013 Method of the year 2012

Targeted Proteomics has been named "Method of the year 2012" by Nature Methods

1/4/2013 Landmark paper in Nature Communications

Biognosys founder Johan Malmstroem publishes landmark paper in the field of targeted proteomics and infectious disease in Nature Communications.

12/7/2012 Closing of financing round

We have closed an intermediate financing round with incumbent and new investors allowing us to further expand our business in Europe and the US.

5/15/2012 iRT paper published in PROTEOMICS 8/12

Our recent paper is published in the latest issue of Proteomics 8/12

1/3/2012 Biognosys and ETH Zurich receive CHF 1.5m funding from CTI

The Swiss Commission for Technology and Innovation (CTI) has granted CHF 1.5m for a research collaboration between Biognosys and the group of Prof. Aebersold, ETH Zurich, to bring the novel HRM-MS technology to the market.

12/7/2011 Biognosys collaborates with M2 to develop commercial MRM software

Biognosys collaborates with M2 to develop commercial MRM software

10/31/2011 Biognosys raises CHF 2.7m in Series A Financing

Biognosys attracted venture capital from experienced investors including Syngenta Ventures.

10/13/2011 Biognosys ranked #12 of TOP100 Swiss Start-Ups

Biognosys ranked #12 of TOP100 Swiss Start-Ups and #3 among Life Science companies.

9/16/2011 iRT concept is gaining acceptance

Biognosys is invited to present its iRT concept for mass spectrometry specialists.

9/9/2011 Biognosys Celebrates 3rd Anniversary!

On September 9th, 2011, Biognosys turns 3 years old...

7/4/2011 Deal with Novartis Vaccines and Diagnostics

Siena, Italy: Biognosys AG is entering into a collaboration with Novartis Vaccines and Diagnostics.


The world's most validated library of mass spec assays

5/24/2011 Biognosys at ASMS / Denver

Biognosys is lecturing and exhibiting at the American Society for Mass Spectrometry Conference 2011 in Denver, Colorado (swing by Booth 28 if you’re attending).


Let us help you do great proteomics!

Please click here to contact us.